Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 139,311 | 5,508 | 27,643 | 202,741 | 207,908 |
| Gross Profit | 139,311 | 5,508 | 27,643 | 202,741 | 207,908 |
| Operating Expenses | 57,843 | 33,604 | 34,676 | 44,667 | 47,133 |
| Operating Income | 81,468 | -28,096 | -7,033 | 158,074 | 160,775 |
| Interest Expense | 0 | 0 | 0 | 0 | 6,811 |
| Other Income | 3,239 | 3,124 | 4,960 | 3,413 | 1,952 |
| Pre-tax Income | 84,707 | -24,972 | -2,073 | 161,487 | 155,916 |
| Income Tax | 24,761 | -3,592 | 250 | 44,266 | 38,915 |
| Net Income Continuous | 59,946 | -21,380 | -2,323 | 117,221 | 117,001 |
| Net Income | $59,946 | $-21,380 | $-2,323 | $117,221 | $117,001 |
| EPS Basic Total Ops | 0.22 | -0.08 | -0.01 | 0.43 | 0.53 |
| EPS Basic Continuous Ops | 0.21 | -0.08 | -0.01 | 0.43 | 0.73 |
| EPS Diluted Total Ops | 0.20 | -0.08 | -0.01 | 0.37 | 0.45 |
| EPS Diluted Continuous Ops | 0.20 | -0.08 | -0.01 | 0.37 | 0.46 |
| EBITDA(a) | $88,226 | $-25,785 | $-2,818 | $162,040 | $164,213 |